Shamburg News · 8-K filed Oct 28, 2026, 5:00 PM EDT

Gain Therapeutics Appoints Jeanette Weidner as Vice President, Finance

GANX · Gain Therapeutics, Inc.

  • Leadership change
  • Material agreement
  • Materiality: medium

On October 22, 2026, Gain Therapeutics, Inc. appointed Jeanette Weidner as Vice President, Finance, effective October 28, 2026, and as principal financial officer and principal accounting officer. The Company entered into an employment agreement with Ms. Weidner providing an annual base salary of $275,000, a target bonus of 35% of base salary, and an option to purchase up to 130,000 shares of common stock. Severance terms include six months of base salary, with enhanced change-of-control benefits.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 5.02, 9.01, accession 0001104659-26-119673.

Written from the filing by Shamburg Markets. Figures are as reported by the company.